CS196641B1 - Method of preparing novel acetylderivatives of 2,4-dinitrophenyl hydrazones of deoxysaccharides having antitumour actions iii - Google Patents
Method of preparing novel acetylderivatives of 2,4-dinitrophenyl hydrazones of deoxysaccharides having antitumour actions iii Download PDFInfo
- Publication number
- CS196641B1 CS196641B1 CS681776A CS681776A CS196641B1 CS 196641 B1 CS196641 B1 CS 196641B1 CS 681776 A CS681776 A CS 681776A CS 681776 A CS681776 A CS 681776A CS 196641 B1 CS196641 B1 CS 196641B1
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- deoxy
- deoxysaccharides
- acetylderivatives
- 4dnfh
- tetra
- Prior art date
Links
- 230000000259 anti-tumor effect Effects 0.000 title claims description 5
- -1 acetylderivatives of 2,4-dinitrophenyl hydrazones Chemical class 0.000 title description 12
- 238000000034 method Methods 0.000 title description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 claims description 9
- 230000003197 catalytic effect Effects 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 1
- 150000003222 pyridines Chemical class 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 239000000126 substance Substances 0.000 description 6
- 150000007857 hydrazones Chemical class 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- KDSPLKNONIUZSZ-NGJCXOISSA-N (2r,4s,5r)-2,4,5,6-tetrahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)C[C@@H](O)C=O KDSPLKNONIUZSZ-NGJCXOISSA-N 0.000 description 2
- FRJOXJBNQDZEBI-HCWXCVPCSA-N (2s,3s,5s)-2,3,5,6-tetrahydroxyhexanal Chemical compound OC[C@@H](O)C[C@H](O)[C@H](O)C=O FRJOXJBNQDZEBI-HCWXCVPCSA-N 0.000 description 2
- KDSPLKNONIUZSZ-HCWXCVPCSA-N (2s,4s,5r)-2,4,5,6-tetrahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)C[C@H](O)C=O KDSPLKNONIUZSZ-HCWXCVPCSA-N 0.000 description 2
- VRYALKFFQXWPIH-PBXRRBTRSA-N (3r,4s,5r)-3,4,5,6-tetrahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)CC=O VRYALKFFQXWPIH-PBXRRBTRSA-N 0.000 description 2
- PNNNRSAQSRJVSB-JGWLITMVSA-N D-quinovose Chemical compound C[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O PNNNRSAQSRJVSB-JGWLITMVSA-N 0.000 description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- FXPDZGXNAIRABP-MCIONIFRSA-N [(2r,3s,4r)-2,3,4-triacetyloxy-6-oxohexyl] acetate Chemical compound CC(=O)OC[C@@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H](CC=O)OC(C)=O FXPDZGXNAIRABP-MCIONIFRSA-N 0.000 description 2
- PMMURAAUARKVCB-UHFFFAOYSA-N alpha-D-ara-dHexp Natural products OCC1OC(O)CC(O)C1O PMMURAAUARKVCB-UHFFFAOYSA-N 0.000 description 2
- SHZGCJCMOBCMKK-PQMKYFCFSA-N alpha-D-rhamnose Chemical compound C[C@H]1O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]1O SHZGCJCMOBCMKK-PQMKYFCFSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- OPVYKVGCFWDTOI-DUDQEUOJSA-N [(2r,3r,4s,5r)-3,4,5-triacetyloxy-6-oxohexan-2-yl] acetate Chemical compound CC(=O)O[C@H](C)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](OC(C)=O)C=O OPVYKVGCFWDTOI-DUDQEUOJSA-N 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 208000035269 cancer or benign tumor Diseases 0.000 description 1
- 230000003327 cancerostatic effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000001668 nucleic acid synthesis Methods 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 229960004295 valine Drugs 0.000 description 1
Landscapes
- Saccharide Compounds (AREA)
Description
Vynález sa týká sposobu přípravy niektorých hydrazónov deoxysacharidpv a ich acetylderivátov ako potenciálny ch kancerostatík. Bolo zistené, že acetylované hydrazóny sacharidov majú protinádorové účinky (K. Linek, J. Fúska, R. Sandtnerová, M. Kulhánek čsl. pat. č. 163115.The invention relates to a process for the preparation of certain derazysaccharide hydrazones and their acetylderivatives as potential cancerostatics. Acetylated hydrazones of saccharides have been found to have antitumor effects (K. Linek, J. Fouska, R. Sandtnerova, M. Kulhanek, U.S. Pat. No. 163115).
Tento, vynález sa týká přípravy nových derivátov s protinádorovými. účinkami á toThis invention relates to the preparation of novel antitumor derivatives. the effects of it
2,4-dinitrofenylhyďrazónov niektorých deoxysachaťidov a ich acetylderivátov(tab: i), ktorá sa vyznačuje tým, že příslušný hydrazón sacharidu sa acetyluje acetanhydridom za katalytického účinku pyridinu pri teplote 0 °C.2,4-dinitrophenylhyrazrazones of some deoxysaccharides and their acetylderivatives (Table 1), characterized in that the corresponding saccharide hydrazone is acetylated with acetic anhydride under the catalytic action of pyridine at 0 ° C.
Látky uvedené v tabulke 1 neboli žatial' v literatúre popíšané. Látky sa identifikovali pomocou bodu topenia, optickej otáčavosti a elementárnou analýzou.The substances listed in Table 1 have not been described in the literature. Substances were identified by melting point, optical rotation and elemental analysis.
Potenciálně protinádorové účinky námi připravených látok sa hodnotili v pokusoch in vitro na buňky EAC. Účinok látok sa hodnotil na základe inhibície inkorpdrácie 14C prekurzorov syntézy proteina a nukleinových kyselin do buněčných frakcif EAC nerozpustných v ladovej trichloroctovej kyselině, metódou, ktorú popísali J. Fuška a spol. Neoplazma 18,631, (1971). Látky inhibovali predovšetkým syntézu nukleinových kyselin a to hlavně RNK (tabulka č. 2).The potential antitumor effects of our compounds were evaluated in in vitro experiments on EAC cells. The effect of the compounds was evaluated by inhibiting the incorporation of 14 C precursors of protein and nucleic acid synthesis into EAC cell fractions insoluble in glacial trichloroacetic acid, by the method described by J. Fuška et al. Neoplasm 18,631, (1971). In particular, the substances inhibited the synthesis of nucleic acids, in particular RNK (Table 2).
Tabulka č. 1Table 1
D25 (C, O, 31, CeHsN) (C, O, 27, C2H5OH) (C, O, 30, C2H5OH) (C, O, 35, CHsOH) (C, O, 28, CH3OH) (C, O, 29, CH3OH) (C, O, 35, CH3COOC2H5) (C, O, 3, CH3COOC2H5)D 25 (C, O, 31, C 6 H 5 N) (C, O, 27, C 2 H 5 OH) (C, O, 30, C 2 H 5 OH) (C, O, 35, CH 3 OH) (C, 0, 28, CH 3 OH) O, 29, CH 3 OH) (C, O, 35, CH 3 COOC 2 H 5) (C, 0, 3, CH 3 COOC 2 H 5)
Příprava 2,4-dinitrofenyl hydrazónov deoxysacharidov mmol deoxysacharidu sa rozpustí v 30 ml etanolu, přidá sa 1 mmol 2,4 dlnitrofenylhydrazínu a 0,05 ml kyseliny octovej a zahřeje do refluxu. Priebeh reakcie sa sleduje pomocou chromatografie na tenkých vrstvách silikagélu (silufol) v systéme chloroform: metanol (6:1). Optimálna doba reakcie je 12 až 15 hod. Potom sa reakčná zmes zahustí, destilačný zbytok sa extrahuje chloroformom a nerozpustný zbytok sa krystalizuje z etanolu, pričom sa získá příslušný hydrazón deoxysacharidu v cca 80% výtažku.Preparation of 2,4-dinitrophenyl hydrazones deoxysaccharides mmol of deoxysaccharide is dissolved in 30 ml of ethanol, 1 mmol of 2,4-dlnitrophenylhydrazine and 0.05 ml of acetic acid are added and heated to reflux. The progress of the reaction was monitored by thin layer chromatography on silica gel (silufol) in chloroform: methanol (6: 1). The optimum reaction time is 12-15 hours. The reaction mixture is then concentrated, the residue is extracted with chloroform and the insoluble residue is crystallized from ethanol to give the corresponding hydrazone deoxysaccharide in about 80% yield.
h. Priebeh reakcie sa sleduje chromato-h. The reaction is monitored by chromatography.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS681776A CS196641B1 (en) | 1976-10-22 | 1976-10-22 | Method of preparing novel acetylderivatives of 2,4-dinitrophenyl hydrazones of deoxysaccharides having antitumour actions iii |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS681776A CS196641B1 (en) | 1976-10-22 | 1976-10-22 | Method of preparing novel acetylderivatives of 2,4-dinitrophenyl hydrazones of deoxysaccharides having antitumour actions iii |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS196641B1 true CS196641B1 (en) | 1980-03-31 |
Family
ID=5416068
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS681776A CS196641B1 (en) | 1976-10-22 | 1976-10-22 | Method of preparing novel acetylderivatives of 2,4-dinitrophenyl hydrazones of deoxysaccharides having antitumour actions iii |
Country Status (1)
| Country | Link |
|---|---|
| CS (1) | CS196641B1 (en) |
-
1976
- 1976-10-22 CS CS681776A patent/CS196641B1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6504029B1 (en) | Condensed-hexacyclic compounds and a process therefor | |
| US3450693A (en) | Method of synthesizing adenosine,2',3'-o-isopropylidene-adenosine and intermediates thereof | |
| HU180892B (en) | Process for preparing 9-/hydroxy-alkyl/-purine derivatives | |
| US2956998A (en) | Adenine derivatives and process | |
| US4567254A (en) | Method for preparing N6,8-disubstituted 3',5'-cyclic adenosine monophosphate and salt thereof | |
| EP0251197A2 (en) | Triterpene saponins having anti-inflammatory, mucolytic and antiedemic activities, process for the preparation thereof and pharmaceutical compositions containing them | |
| CS196641B1 (en) | Method of preparing novel acetylderivatives of 2,4-dinitrophenyl hydrazones of deoxysaccharides having antitumour actions iii | |
| Stanek et al. | Synthesis and aromatase inhibitory activity of novel 1-(4-aminophenyl)-3-azabicyclo [3.1. 0] hexane-and-[3.1. 1] heptane-2, 4-diones | |
| Sugasawa et al. | Experiments on the synthesis of dl-camptothecin. 4. Synthesis and antileukemic activity of dl-camptothecin analogues | |
| Baker et al. | PUROMYCIN. SYNTHETIC STUDIES. IV. GLUCOSYL DERIVATIVES OF 6-DIMETHYLAMINOPURINE | |
| US4085270A (en) | Sympathicomimetic acyloxy-phenylethanolamine | |
| JP2000503666A (en) | Camptothecin isolated from Mappia foetida-backbone compounds and their use as synthons for novel pharmaceutical and therapeutic agents | |
| BE779775A (en) | DERIVATIVES OF UREA, METHOD FOR PREPARING THEM AND THEIR APPLICATIONS | |
| SU703024A3 (en) | Method of preparing dimeric 1-formylindole dihydroindole or its salts | |
| Dutta et al. | Synthesis and properties of the naturally occurring N-[(9-β-D-ribofuranosylpurin-6-yl)-N-methylcarbamoyl]-L-threonine (mt6A) and other related synthetic analogs | |
| EP0021991A1 (en) | Cystamine derivatives, their preparation and pharmaceutical compositions containing them | |
| SU1251806A3 (en) | Method of producing 7-substituted 9a-methoxymitosane | |
| US4587052A (en) | 1H-pyrrolo-[2,1-C][1,4]benzodiazepine-2-acrylamide compounds having antitumor activity | |
| Kato et al. | " Reduced" analogs of puromycin. Synthesis of 3'-O-(L-2-amino-3-phenylpropyl)-N6, N6-dimethyladenosine and the corresponding 2'isomer | |
| US3743660A (en) | 17-sulfo-acetates of estradiol | |
| JPH0745498B2 (en) | t-butyl ergoline derivative | |
| US4075214A (en) | Preparation of leurosidine and novel leurosidine 4'-ethers and esters | |
| CA2227513C (en) | New ellipticine derivatives, their preparation process and the pharmaceutical compositions containing them | |
| US3380994A (en) | Coumermycin derivatives | |
| Walton et al. | 1-p-Chlorobenzyl-5-methylindole-3-acetic Acid. Some 2-Substituted Derivatives |